Abstract
Antioxidant potential of some β-ionyl compounds has been assessed by examining their ability to protect methyl linoleate from aerial and 2,2-azobisisobutyronitrile-induced radical-mediated oxidation. It is observed that the π- electron density of β-ionyl structure is an important factor in the antiradical activity of these compounds.
Keywords: β-Ionone, retinoids, antiradical, antioxidants, radioprotectants, peroxidation, methyl linoleate, AIBN
Letters in Organic Chemistry
Title: Antiradical Activity of β-Ionyl Compounds
Volume: 7 Issue: 4
Author(s): Anil K. Singh and Solomon B. Libsu
Affiliation:
Keywords: β-Ionone, retinoids, antiradical, antioxidants, radioprotectants, peroxidation, methyl linoleate, AIBN
Abstract: Antioxidant potential of some β-ionyl compounds has been assessed by examining their ability to protect methyl linoleate from aerial and 2,2-azobisisobutyronitrile-induced radical-mediated oxidation. It is observed that the π- electron density of β-ionyl structure is an important factor in the antiradical activity of these compounds.
Export Options
About this article
Cite this article as:
K. Singh Anil and B. Libsu Solomon, Antiradical Activity of β-Ionyl Compounds, Letters in Organic Chemistry 2010; 7 (4) . https://dx.doi.org/10.2174/157017810791130603
DOI https://dx.doi.org/10.2174/157017810791130603 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Conditionally Replicating Adenoviruses for Cancer Treatment
Current Cancer Drug Targets The Urokinase Receptor as a Potential Target in Cancer Therapy
Current Pharmaceutical Design Strategies for the Biological Evaluation of Gold Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Undermining Tumor Angiogenesis by Gene Therapy: An Emerging Field
Current Gene Therapy Editorial: [Hot Topic: Inflammation and Cancer: New Targets and Novel Therapeutic Approach]
Current Pharmaceutical Design Advances in Lentiviral Vectors: A Patent Review
Recent Patents on DNA & Gene Sequences Signaling Pathways Responsible for Cancer Cell Invasion as Targets for Cancer Therapy
Current Cancer Drug Targets Targeted Therapy of Ovarian Cancer with Angiogenesis Inhibitors
Current Drug Targets Identification of Tyrosine Kinase Src Responsible for Antimicrobial Peptides Production in Bombyx mori
Protein & Peptide Letters Hypomethylation and Activation of Syncytin-1 Gene in Endometriotic Tissue
Current Pharmaceutical Design Role of Azoles in Cancer Prevention and Treatment: Present and Future Perspectives
Anti-Cancer Agents in Medicinal Chemistry DLX6-AS1: An Indispensable Cancer-related Long Non-coding RNA
Current Pharmaceutical Design ANTI-ADHESION Evolves To a Promising Therapeutic Concept in Oncology
Current Medicinal Chemistry Elastic Liposomes for Topical and Transdermal Drug Delivery
Current Drug Delivery Patents on Immunotoxins and Chimeric Toxins for the Treatment of Cancer
Recent Patents on Drug Delivery & Formulation Radionuclide Antibody-Conjugates, a Targeted Therapy Towards Cancer
Current Radiopharmaceuticals Onconeural Versus Paraneoplastic Antigens?
Current Medicinal Chemistry Nanomaterials as Emerging Environmental Threats
Current Chemical Biology Carrier Deformability in Drug Delivery
Current Pharmaceutical Design Update on the Rheumatologic Manifestations of Malignancy
Current Cancer Therapy Reviews